ACM
TARO

Ativo Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Ativo Capital Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-78,727
Closed -$8.7M – 238
2016
Q3 		$8.7M Buy
78,727
+259
+0.3% +$34.3K 2.01% 7
2016
Q2 		$11.4M Buy
78,468
+4,542
+6% +$644K 2.79% 3
2016
Q1 		$10.6M Sell
73,926
-417
-0.6% -$59.2K 2.87% 4
2015
Q4 		$11.5M Buy
74,343
+11,956
+19% +$1.75M 2.88% 5
2015
Q3 		$8.74M Buy
62,387
+8,253
+15% +$1.15M 2.33% 6
2015
Q2 		$7.5M Sell
54,134
-1,739
-3% -$248K 2.64% 6
2015
Q1 		$7.88M Buy
55,873
+695
+1% +$107K 3.09% 4
2014
Q4 		$8.18M Buy
55,178
+6,036
+12% +$887K 3.36% 3
2014
Q3 		$7.56M Buy
49,142
+31,084
+172% +$4.68M 2.98% 2
2014
Q2 		$2.53M Sell
18,058
-4,833
-21% -$537K 1.1% 31
2014
Q1 		$2.54M Buy
22,891
+63
+0.3% +$6.86K 1.03% 32
2013
Q4 		$2.26M Sell
22,828
-2,735
-11% -$237K 0.99% 35
2013
Q3 		$1.94M Sell
25,563
-6,027
-19% -$391K 0.92% 40
2013
Q2 		$1.77M Buy
+31,590
New +$1.87M 0.91% 45

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ativo Capital Management's TARO Position: Q4 2016 in Review

Ativo Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2016, closing a stake of 78,727 shares — an estimated $8.7M sold.

Ativo Capital Management first reported a position in TARO in Q2 2013 and held it in 14 quarters. The position peaked at $11.5M in Q4 2015. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

  • Ativo Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2016 after selling out during the quarter.
  • Ativo Capital Management sold 78,727 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $8.7M.
  • Ativo Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 14 quarters.
  • Ativo Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $11.5M in Q4 2015.
  • 151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on Ativo Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.